Skip to main content
Log in

Serum adipocyte fatty acid-binding protein level is associated with arterial stiffness quantified with cardio-ankle vascular index in kidney transplant patients

  • Original article
  • Published:
Clinical and Experimental Nephrology Aims and scope Submit manuscript

Abstract

Background

Arterial stiffness is an established marker of cardiovascular risk and an independent predictor of cardiovascular disease (CVD) events and mortality in kidney transplant (KT) patients. Adipocyte fatty acid-binding protein (A-FABP), a novel adipokine, is positively associated with atherosclerosis. The present study evaluated the relationship between fasting circulating A-FABP and peripheral arterial stiffness using the cardio-ankle vascular index (CAVI) in KT patients.

Methods

Fasting blood samples were collected from 74 KT patients, and serum A-FABP levels were measured using an enzyme immunoassay. CAVI was calculated using a waveform device (CAVI-VaSera VS-1000). The cutoff values for high and low levels of arterial stiffness were defined by the CAVI values of ≥9 and <9, respectively.

Results

Thirty-four patients (45.9%) were classified into the high arterial stiffness group. Compared with the low arterial stiffness group, the high arterial stiffness group had higher values for age (p = 0.015), systolic blood pressure (p < 0.001), pulse pressure (p < 0.001), duration of kidney transplantation (p = 0.005), serum total cholesterol and triglyceride levels (p = 0.033 and 0.047, respectively), glomerular filtration rate (p = 0.019), fasting glucose levels (p = 0.012), and serum A-FABP levels (p < 0.001). Multivariate forward stepwise linear regression analysis showed that age (p = 0.004), systolic blood pressure (p = 0.001), and serum A-FABP levels (p = 0.003) were independent predictors of CAVI value in KT patients.

Conclusion

Serum fasting A-FABP level is positively associated with peripheral arterial stiffness in KT patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Makowski L, Hotamisligil GS. Fatty acid binding proteins—the evolutionary crossroads of inflammatory and metabolic responses. J Nutr. 2004;134(9):2464S–8S.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Krusinova E, Pelikanova T. Fatty acid binding proteins in adipose tissue: a promising link between metabolic syndrome and atherosclerosis? Diabetes Res Clin Pract. 2008;82(Suppl 2):S127–34.

    Article  CAS  PubMed  Google Scholar 

  3. Boord JB, Fazio S, Linton MF. Cytoplasmic fatty acid-binding proteins: emerging roles in metabolism and atherosclerosis. Curr Opin Lipidol. 2002;13(2):141–7.

    Article  CAS  PubMed  Google Scholar 

  4. Xu A, Tso AW, Cheung BM, Wang Y, Wat NM, Fong CH, et al. Circulating adipocyte-fatty acid binding protein levels predict the development of the metabolic syndrome: a 5-year prospective study. Circulation. 2007;115(12):1537–43.

    Article  CAS  PubMed  Google Scholar 

  5. Yeung DC, Xu A, Cheung CW, Wat NM, Yau MH, Fong CH, et al. Serum adipocyte fatty acid-binding protein levels were independently associated with carotid atherosclerosis. Arterioscler Thromb Vasc Biol. 2007;27(8):1796–802.

    Article  CAS  PubMed  Google Scholar 

  6. Delahousse M, Chaignon M, Mesnard L, Boutouyrie P, Safar ME, Lebret T, et al. Aortic stiffness of kidney transplant recipients correlates with donor age. J Am Soc Nephrol. 2008;19(4):798–805.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Kneifel M, Scholze A, Burkert A, Offermann G, Rothermund L, Zidek W, et al. Impaired renal allograft function is associated with increased arterial stiffness in renal transplant recipients. Am J Transplant. 2006;6(7):1624–30.

    Article  CAS  PubMed  Google Scholar 

  8. Hornum M, Clausen P, Idorn T, Hansen JM, Mathiesen ER, Feldt-Rasmussen B. Kidney transplantation improves arterial function measured by pulse wave analysis and endothelium-independent dilatation in uraemic patients despite deterioration of glucose metabolism. Nephrol Dial Transplant. 2011;26(7):2370–7.

    Article  CAS  PubMed  Google Scholar 

  9. Shirai K, Utino J, Otsuka K, Takata M. A novel blood pressure-independent arterial wall stiffness parameter; cardio-ankle vascular index (CAVI). J Atheroscler Thromb. 2006;13(2):101–7.

    Article  PubMed  Google Scholar 

  10. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15(7):539–53.

    Article  CAS  PubMed  Google Scholar 

  11. Chen YC, Lee MC, Lee CJ, Ho GJ, Yin WY, Chang YJ, et al. N-terminal pro-B-type natriuretic peptide is associated with arterial stiffness measured using the cardio-ankle vascular index in renal transplant recipients. J Atheroscler Thromb. 2013;20(7):646–53.

    Article  CAS  PubMed  Google Scholar 

  12. Lee CJ, Wang JH, Chen ML, Yang CF, Chen YC, Hsu BG. Serum osteoprotegerin is associated with arterial stiffness assessed according to the cardio-ankle vascular index in hypertensive patients. J Atheroscler Thromb. 2015;22(3):304–12.

    Article  CAS  PubMed  Google Scholar 

  13. Hsu BG, Chen YC, Lee RP, Lee CC, Lee CJ, Wang JH. Fasting serum level of fatty-acid-binding protein 4 positively correlates with metabolic syndrome in patients with coronary artery disease. Circ J. 2010;74(2):327–31.

    Article  CAS  PubMed  Google Scholar 

  14. Tsai JP, Liou HH, Liu HM, Lee CJ, Lee RP, Hsu BG. Fasting serum fatty acid-binding protein 4 level positively correlates with metabolic syndrome in hemodialysis patients. Arch Med Res. 2010;41(7):536–40.

    Article  CAS  PubMed  Google Scholar 

  15. Tsai JP, Wang JH, Lee CJ, Chen YC, Hsu BG. Positive correlation of serum adipocyte fatty acid binding protein levels with carotid-femoral pulse wave velocity in geriatric population. BMC Geriatr. 2015;15:88.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Fukuda-Denshi Company, Tokyo, Japan (2017). http://www.fukuda.co.jp/english/products/special_features/vasera/cavi.html. Accessed 20 March 2017.

  17. Kawasaki T, Sasayama S, Yagi S, Asakawa T, Hirai T. Non-invasive assessment of the age related changes in stiffness of major branches of the human arteries. Cardiovasc Res. 1987;21(9):678–87.

    Article  CAS  PubMed  Google Scholar 

  18. Bramwell JC, Hill AV. The velocity of the pulse wave in man. Proc R Soc Lond Ser B Contain Pap Biol Character. 1922;93(652):298–306.

    Article  Google Scholar 

  19. Shirai K, Hiruta N, Song M, Kurosu T, Suzuki J, Tomaru T, et al. Cardio-ankle vascular index (CAVI) as a novel indicator of arterial stiffness: theory, evidence and perspectives. J Atheroscler Thromb. 2011;18(11):924–38.

    Article  PubMed  Google Scholar 

  20. Shirai K, Song M, Suzuki J, Kurosu T, Oyama T, Nagayama D, et al. Contradictory effects of beta1- and alpha1-aderenergic receptor blockers on cardio-ankle vascular stiffness index (CAVI)–CAVI independent of blood pressure. J Atheroscler Thromb. 2011;18(1):49–55.

    Article  CAS  PubMed  Google Scholar 

  21. Takaki A, Ogawa H, Wakeyama T, Iwami T, Kimura M, Hadano Y, et al. Cardio-ankle vascular index is a new noninvasive parameter of arterial stiffness. Circ J. 2007;71(11):1710–4.

    Article  CAS  PubMed  Google Scholar 

  22. Lim J, Pearman ME, Park W, Alkatan M, Machin DR, Tanaka H. Impact of blood pressure perturbations on arterial stiffness. Am J Physiol Regul Integr Comp Physiol. 2015;309(12):R1540–5.

    Article  CAS  PubMed  Google Scholar 

  23. Ibata J, Sasaki H, Kakimoto T, Matsuno S, Nakatani M, Kobayashi M, et al. Cardio-ankle vascular index measures arterial wall stiffness independent of blood pressure. Diabetes Res Clin Pract. 2008;80(2):265–70.

    Article  PubMed  Google Scholar 

  24. Okura T, Watanabe S, Kurata M, Manabe S, Koresawa M, Irita J, et al. Relationship between cardio-ankle vascular index (CAVI) and carotid atherosclerosis in patients with essential hypertension. Hypertens Res. 2007;30(4):335–40.

    Article  PubMed  Google Scholar 

  25. Takaki A, Ogawa H, Wakeyama T, Iwami T, Kimura M, Hadano Y, et al. Cardio-ankle vascular index is superior to brachial-ankle pulse wave velocity as an index of arterial stiffness. Hypertens Res. 2008;31(7):1347–55.

    Article  PubMed  Google Scholar 

  26. Bokuda K, Ichihara A, Sakoda M, Mito A, Kinouchi K, Itoh H. Blood pressure-independent effect of candesartan on cardio-ankle vascular index in hypertensive patients with metabolic syndrome. Vasc Health Risk Manag. 2010;6:571–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Namekata T, Suzuki K, Ishizuka N, Shirai K. Establishing baseline criteria of cardio-ankle vascular index as a new indicator of arteriosclerosis: a cross-sectional study. BMC Cardiovasc Disord. 2011;11:51.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Soska V, Frantisova M, Dobsak P, Dusek L, Jarkovsky J, Novakova M, et al. Cardio-ankle vascular index in subjects with dyslipidaemia and other cardiovascular risk factors. J Atheroscler Thromb. 2013;20(5):443–51.

    Article  PubMed  Google Scholar 

  29. Gomez-Sanchez L, Garcia-Ortiz L, Patino-Alonso MC, Recio-Rodriguez JI, Fernando R, Marti R, et al. Association of metabolic syndrome and its components with arterial stiffness in Caucasian subjects of the MARK study: a cross-sectional trial. Cardiovasc Diabetol. 2016;15(1):148.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Xu A, Wang Y, Xu JY, Stejskal D, Tam S, Zhang J, et al. Adipocyte fatty acid-binding protein is a plasma biomarker closely associated with obesity and metabolic syndrome. Clin Chem. 2006;52(3):405–13.

    Article  CAS  PubMed  Google Scholar 

  31. Boord JB, Maeda K, Makowski L, Babaev VR, Fazio S, Linton MF, et al. Combined adipocyte-macrophage fatty acid-binding protein deficiency improves metabolism, atherosclerosis, and survival in apolipoprotein E-deficient mice. Circulation. 2004;110(11):1492–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Furuhashi M, Fucho R, Gorgun CZ, Tuncman G, Cao H, Hotamisligil GS. Adipocyte/macrophage fatty acid-binding proteins contribute to metabolic deterioration through actions in both macrophages and adipocytes in mice. J Clin Invest. 2008;118(7):2640–50.

    CAS  PubMed  PubMed Central  Google Scholar 

  33. Erbay E, Babaev VR, Mayers JR, Makowski L, Charles KN, Snitow ME, et al. Reducing endoplasmic reticulum stress through a macrophage lipid chaperone alleviates atherosclerosis. Nat Med. 2009;15(12):1383–91.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Mohlig M, Weickert MO, Ghadamgadai E, Machlitt A, Pfuller B, Arafat AM, et al. Adipocyte fatty acid-binding protein is associated with markers of obesity, but is an unlikely link between obesity, insulin resistance, and hyperandrogenism in polycystic ovary syndrome women. Eur J Endocrinol. 2007;157(2):195–200.

    Article  PubMed  Google Scholar 

  35. Stejskal D, Karpisek M. Adipocyte fatty acid binding protein in a Caucasian population: a new marker of metabolic syndrome? Eur J Clin Invest. 2006;36(9):621–5.

    Article  CAS  PubMed  Google Scholar 

  36. Furuhashi M, Ishimura S, Ota H, Hayashi M, Nishitani T, Tanaka M, et al. Serum fatty acid-binding protein 4 is a predictor of cardiovascular events in end-stage renal disease. PLoS One. 2011;6(11):e27356.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Zoccali C, Mallamaci F, Tripepi G, Benedetto FA, Cutrupi S, Parlongo S, et al. Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. J Am Soc Nephrol. 2002;13(1):134–41.

    CAS  PubMed  Google Scholar 

  38. Ebert T, Hopf LM, Wurst U, Bachmann A, Kralisch S, Lossner U, et al. Circulating adipocyte fatty acid binding protein is increased in chronic and acute renal dysfunction. Nutr Metab Cardiovasc Dis. 2014;24(9):1027–34.

    Article  CAS  PubMed  Google Scholar 

  39. Tanaka M, Furuhashi M, Okazaki Y, Mita T, Fuseya T, Ohno K, et al. Ectopic expression of fatty acid-binding protein 4 in the glomerulus is associated with proteinuria and renal dysfunction. Nephron Clin Pract. 2014;128(3–4):345–51.

    CAS  PubMed  Google Scholar 

  40. Iwamoto M, Miyoshi T, Doi M, Takeda K, Kajiya M, Nosaka K, et al. Elevated serum adipocyte fatty acid-binding protein concentrations are independently associated with renal dysfunction in patients with stable angina pectoris. Cardiovasc Diabetol. 2012;11:26.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Agardh HE, Folkersen L, Ekstrand J, Marcus D, Swedenborg J, Hedin U, et al. Expression of fatty acid-binding protein 4/aP2 is correlated with plaque instability in carotid atherosclerosis. J Intern Med. 2011;269(2):200–10.

    Article  CAS  PubMed  Google Scholar 

  42. Peeters W, de Kleijn DP, Vink A, van de Weg S, Schoneveld AH, Sze SK, et al. Adipocyte fatty acid binding protein in atherosclerotic plaques is associated with local vulnerability and is predictive for the occurrence of adverse cardiovascular events. Eur Heart J. 2011;32(14):1758–68.

    Article  CAS  PubMed  Google Scholar 

  43. Furuhashi M, Fuseya T, Murata M, Hoshina K, Ishimura S, Mita T, et al. Local Production of Fatty Acid-Binding Protein 4 in Epicardial/Perivascular Fat and Macrophages Is Linked to Coronary Atherosclerosis. Arterioscler Thromb Vasc Biol. 2016;36(5):825–34.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This study was supported by a Grant from Buddhist Tzu Chi General Hospital, Hualien, Taiwan (TCRD-101-06).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ming-Che Lee.

Ethics declarations

Conflict of interest

The authors have declared that no conflict of interest exists.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee at which the studies were conducted (IRB approval number 100-91) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chen, YC., Hsu, BG., Lee, CJ. et al. Serum adipocyte fatty acid-binding protein level is associated with arterial stiffness quantified with cardio-ankle vascular index in kidney transplant patients. Clin Exp Nephrol 22, 188–195 (2018). https://doi.org/10.1007/s10157-017-1438-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10157-017-1438-1

Keywords

Navigation